Dea Proposed Rule:

[BoonDoc]

For those of us who take schedule II medications, and receive the meds from the VA, this proposed rule would make the 90 day supple available to us again. This means that you don't have to waite and worry about them sending the meds, and having to wait and be home to sign for the meds, or miss the mail and have the meds sent back...and run out of required meds. What a pain! pun intended :D :

Federal Register Notices > Rules - 2006 > Proposed Rule: Issuance of Multiple Prescriptions for Schedule II Controlled Substances

Rules - 2006

--------------------------------------------------------------------------------

FR Doc E6-14520 [Federal Register: September 6, 2006 (Volume 71, Number 172)] [Proposed Rules] [Page 52724-52726] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06se06-43]

[[Page 52724]]

--------------------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

21 CFR Part 1306

[Docket No. DEA-287N] RIN 1117-AB01

Issuance of Multiple Prescriptions for Schedule II Controlled Substances

AGENCY: Drug Enforcement Administration (DEA), Justice.

ACTION: Notice of proposed rulemaking.

--------------------------------------------------------------------------------

SUMMARY: DEA is hereby proposing to amend its regulations to allow practitioners to provide individual patients with multiple prescriptions, to be filled sequentially, for the same schedule II controlled substance, with such multiple prescriptions having the combined effect of allowing a patient to receive over time up to a 90- day supply of that controlled substance. DEA is requesting public comment on this proposed rule.

DATES: Written comments must be postmarked, and electronic comments must be sent, on or before November 6, 2006.

ADDRESSES: Please submit comments, identified by "Docket No. DEA- 287N,'' by one of the following methods:

1. Regular mail: Deputy Administrator, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative/ODL.

2. Express mail: DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, VA 22301.

3. E-mail comments directly to agency: dea.diversion.policy@usdoj.gov.

4. Federal eRulemaking portal: http://www.regulations.gov. Follow the on-line instructions for submitting comments.

Anyone planning to comment should be aware that all comments received before the close of the comment period will be made available in their entirety for public inspection, including any personal information submitted. For those submitting comments electronically, DEA will accept attachments only in the following formats: Microsoft Word; WordPerfect; Adobe PDF; or Excel.

FOR FURTHER INFORMATION CONTACT: Mark W. Caverly, Chief, Liaison and Policy Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537; Telephone: (202) 307-7297.

Edited October 8, 2006 by BoonDoc